New Year, Same Problems In Supplement Arena: GMPs, Disease Claims
This article was originally published in The Tan Sheet
Executive Summary
Nine warnings published March 8 identify GMP violations FDA officials commonly have found since beginning those inspections in 2010 and also note additional examples of firms distributing products that contain undeclared drug ingredients as well as making disease claims for their products.